Pirtobrutinib (Jaypirca®), a first-in-class noncovalent Bruton tyrosine kinase (BTK) inhibitor, has been approved by the FDA ...

Curis, Inc. , a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today announced that it has entered into a ...

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show ...

For patients with Waldenström macroglobulinemia (WM), transitioning from ibrutinib (Imbruvica) to zanubrutinib (Brukinsa) may offer comparable clinical outcomes, as suggested by interim data from a ...

The therapy is a highly advanced form of radiation therapy that uses charged particles in the form of a proton that that gets ...

According to the World Health Organization, each year cervical cancer impacts approximately 600,000 women throughout the ...

From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show that cancer drug treatments can be safely and effectively personalized based ...

A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living ...

Medigap Plan G from AARP/UnitedHealthcare and a Medicare Part D plan from Wellcare are the best Medicare plans for cancer patients. If you can't get Medigap because of your cancer diagnosis, consider ...

The question of how to treat neck wrinkles looms large in a beauty routine sooner than one might think. While the face may look firm and fresh, “the neck skin tends to age faster than our face because ...